Clinical & Experimental Allergy

Meeting the information needs of patients with allergic disorders: partnership is the key
pp. 1333-1335(3)

Plant non-specific lipid transfer proteins as food and pollen allergens
pp. 1336-1341(6)
Authors: G. Salcedo; R. Sanchez-Monge; A. Diaz-Perales; G. Garcia-Casado; D. Barber

Anti-inflammatory properties of desloratadine
pp. 1342-1348(7)
Author: D. K. Agrawal

Mode of delivery is not associated with asthma or atopy in childhood
pp. 1349-1355(7)
Authors: A. Maitra; A. Sherriff; D. Strachan; J. Henderson

Altered ₂-adrenergic regulation of T cell activity after allergen challenge in asthma
pp. 1356-1363(8)
Authors: I. H. Heijink; M. van den Berge; E. Vellenga; J. G. R. de Monchy; D. S. Postma; H. F. Kauffman

Defective suppression of Th2 cytokines by CD4⁺CD25⁺ regulatory T cells in birch allergics during birch pollen season
pp. 1364-1372(9)
Authors: H. Grindebacke; K. Wing; A.-C. Andersson; E. Suri-Payer; S. Rak; A. Rudin

Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells
pp. 1373-1378(6)
Authors: L. K. Wilcock; J. N. Francis; S. R. Durham

CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate
pp. 1379-1387(9)
Authors: G. Woerly; V. Decot; S. Loiseau; M. Loyens; J. Chihara; N. Ono; M. Capron

Effect of montelukast compared with inhaled fluticasone on airway inflammation
pp. 1388-1394(7)
Authors: S. E. Overbeek; S. O'Sullivan; K. Leman; P. G. H. Mulder; H. C. Hoogsteden; J.-B. Prins

Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery
pp. 1395-1400(6)
Authors: M. D. Dijkstra; F. A. Ebbens; R. M. L. Poublon; W. J. Fokkens

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study
pp. 1401-1407(7)
Authors: E. Nettis; M. C. Colanardi; M. T. Paradiso; A. Ferrannini

Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study
pp. 1408-1414(7)
Authors: C. Mirone; F. Albert; A. Tosi; F. Mocchetti; S. Mosca; M. Giorgino; S. Pecora; S. Parmiani; C. Ortolani

Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens
pp. 1415-1421(7)
Authors: M. Lombardero; F. J. García-Sellés; F. Polo; L. Jimeno; M. J. Chamorro; G. García-Casado; R. Sánchez-Monge; A. Díaz-Perales; G. Salcedo; D. Barber

Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model
pp. 1422-1428(7)
Authors: F. van Wijk; S. Hartgring; S. J. Koppelman; R. Pieters; L. M. J. Knippels

In vitro allergenicity of peanut after hydrolysis in the presence of polysaccharides
pp. 1429-1437(9)
Authors: J. Mouécoucou; S. Frémont; C. Sanchez; C. Villaume; L. Méjean

A survey of the quality of information leaflets on hayfever available from general practices and community pharmacies
pp. 1438-1443(6)
Authors: P. White; H. Smith; F. Webley; A. Frew

Differential effect of mattress covers on the level of Der p 1 and Der f 1 in dust
pp. 1444-1447(4)
Authors: . Tempels-Pavlica; A. J. Oosting; I. Terreehorst; R. Gerth van Wijk; C. A. F. M. Bruijnzeel-Koomen; J. G. R. de Monchy; R. C. Aalberse

The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome
pp. 1448-1457(10)
Authors: P. Gamboa; M. L. Sanz; M. R. Caballero; I. Urrutia; I. Antépara; R. Esparza; A. L. de Weck

Analysis of effector and regulatory immune reactivity to nickel
pp. 1458-1466(9)
Authors: T. Rustemeyer; B. M. E. von Blomberg; I. M. W. van Hoogstraten; D. P. Bruynzeel; R. J. Scheper

Increase of CC chemokine receptor 4-positive cells in the peripheral CD4⁺ cells in dogs with atopic dermatitis or experimentally sensitized to Japanese cedar pollen
pp. 1467-1473(7)
Authors: S. Maeda; K. Ohmori; N. Yasuda; K. Kurata; M. Sakaguchi; K. Masuda; K. Ohno; H. Tsujimoto

Nerve growth factor-induced substance P in capsaicin-insensitive vagal neurons innervating the lower mouse airway
pp. 1474-1479(6)
Authors: Q. T. Dinh; D. A. Groneberg; C. Peiser; J. Springer; R. A. Joachim; P. C. Arck; B. F. Klapp; A. Fischer

Interleukin-1 attenuates endothelin B receptor-mediated airway contractions in a murine in vitro model of asthma: roles of endothelin converting enzyme and mitogen-activated protein kinase pathways
pp. 1480-1487(8)
Authors: Y. Zhang; M. Adner; L.-O. Cardell

Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma
pp. 1488-1497(10)
Authors: D. P. Ennis; J. P. Cassidy; B. P. Mahon

Regarding Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS & Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy 2004; 34:332–9: Comments regarding ‘In vitro allergy diagnosis: should we follow the flow?’ by Ebo et al. S. M. Erdmann, B. Sachs, K. Hoffmann-Sommergruber, O. Scheinerand H. Merk
pp. 1498-1499(2)

Response by authors: In vitro allergy diagnosis: should we follow the flow? D. G. Ebo, M. M. Hagendorens, C. H. Bridts, A. J. Schuerwegh, L. S. De Clerck and W. J. Stevens
pp. 1499-1500(2)

Forthcoming meetings
pp. 1501-1501(1)